Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ONXX -- Ignore unavailable to you. Want to Upgrade?

To: Uncle Frank who wrote (185)	4/29/1998 12:56:00 PM
From: Marc Bertoglio	Read Replies (1) \| Respond to of 810

ASCO-Conference is taking place between 16. and 20. May. and Onyx will speak about Onyx-15 on 18th (pm.) and 19th May (am.) (You can check that on the ASCO-page: asco.infostreet.com ) Sorry for my wrong indication. Anyway, I personally think Onyx will pass theirs I/II-trials, which is not hard and common for most drugs on this stage. Drugs fail on the III-phase-trials, where you also see the largest impact on stock prices in both directions. In my opinion you should hold the stock 'til news is out and then sell it relatively quick because it won't happen much after that for a long time ('til Dec.). good luck